Navigation Links
Silence Therapeutics Announces Board Changes
Date:7/1/2008

Appoints Annette Clancy and Jerry Randall as non-executive directors

LONDON, July 1 /PRNewswire/ -- Silence Therapeutics plc (London AIM: SLN) ('the Company') today announced changes to its Board of Directors as part of the company's plan for growth.

Effective today, Silence has appointed Annette Clancy and Jerry Randall as non-executive directors and Iain Rugheimer has resigned as a director of the Company.

Annette Clancy is joining the Board in her first non-executive director role. Ms. Clancy (53) is currently with GlaxoSmithKline (GSK), where she has had a distinguished career spanning 30 years, and will be leaving GSK at the end of the year. She has 15 years experience in Business Development, leading GSK's global Transactions and Alliance Management teams for the past 3 years, and during her tenure she and her team have been responsible for concluding a large number of research, development and commercial business collaborations on behalf of GSK. Prior to her role in Business Development, Ms. Clancy held a number of positions in Clinical Research, R&D project management and Commercialization. Ms. Clancy has a BSc (Hons) Pharmacology from Bath University.

Jerry Randall has been Chief Financial Officer of Sinclair Pharmaceuticals plc since 2000 when he joined as part of a management buy-in team. Prior to this, Mr. Randall worked in corporate finance with Gambit Corporate Finance. Previously, Mr. Randall had been involved in two other buy-ins and acted as adviser to both private and quoted companies between 1993 and 2000, in both the capacity as nominated adviser and in practice with KPMG. During this period, Mr. Randall (43) was involved in a number of flotations and transactions on the Official List, Unlisted Securities Market and the Alternative Investment Market, as well as raising private equity. Mr. Randall qualified as a chartered accountant with KPMG in 1990. Mr. Randall has a beneficial interest in 10,000 ordinary share
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 DUSA Pharmaceuticals...mpany that is developing and marketing Levulan(... focused on patients with common skin conditions, ...utive Officer, will present a corporate overview a... Tuesday, November 10, 2009 at 10:00 a.m. ET at th...
(Date:11/6/2009)... Repossessions and liquidations of... quarter of 2009 declined as compared to similar f...ment,s NasTrac Quarterly Index (NQI). The figures...oth repossessions and orderly liquidations, also i...tion and printing equipment, offering mixed news o...
(Date:11/6/2009)...Newswire-USNewswire/ -- America,s Specialty Medici... mid-market and smaller innovator pharmaceutical c..., the "Affordable Health Care for America Act," in...smaller companies fear that the cumulative effect ...heir efforts to bring new medicines to market. ,...
Breaking Medicine Technology:NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Hundreds of Genes Could Be Linked to ADHD 50082 1Hundreds of Genes Could Be Linked to ADHD 50082 2Nations first childrens hospital based safety store focuses on child injury prevention 50079 1Nations first childrens hospital based safety store focuses on child injury prevention 50079 2Health care outcome boost needs better studies 50076 1Health care outcome boost needs better studies 50076 2Health care outcome boost needs better studies 50076 3Health care outcome boost needs better studies 50076 4
...Determine Phase 2 Dosing Regimen -, SOUTH SAN FRA...c., a privately held company focused on the develo...or cancer, today announced,updated results from an...inical trial of RAV12, its lead therapeutic antibo...omas. The objectives of the study were to,define t...
...erapy Proven to Significantly Improve Overall Surv...Cancer, WAYNE, N.J. and EMERYVILLE, Calif., Nov. ...maceuticals, Inc. (Nasdaq:,ONXX) today announced t...s,approved a supplemental New Drug Application for...of patients with unresectable hepatocellular,carci...
Other Medicine Technology:Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 2Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 2Nexavar First FDA-Approved Drug Therapy for Liver Cancer 3Nexavar First FDA-Approved Drug Therapy for Liver Cancer 4Nexavar First FDA-Approved Drug Therapy for Liver Cancer 5Nexavar First FDA-Approved Drug Therapy for Liver Cancer 6
(Date:11/8/2009)...h holds open house at Victoria campus , ...09 -- UCW Academy of Health invites anyone looking...lth care industry to attend their open house in Vi...ademy of Health, which offers diplomas in areas su... designs its programs to meet the needs of the hea...
(Date:11/8/2009)...e/ -- Speaker Nancy Pelosi and Democratic leaders ...e of H.R. 3962, the Affordable Health Care for Ame.... Below are the Speaker,s opening remarks: ,,... from the President of the United States, Barack O... American people. I thank the President for his tr...
(Date:11/8/2009)...is pleased to announce that it has been successful...nd who recently received an award on the $800 mill...ludes not only the Veterans Administration, but al...ncies. , New York, NY (PR...eased to announce that it has been successful in p...
(Date:11/8/2009)...n the Western District of Pennsylvania award a Fay... for a medical malpractice case. Attorneys Thomas...s E. Crenney and Associates, LLC handled the case ...gainst the Uniontown Hospital. The woman had to h...ge 18. , Pittsburgh, PA(P...
(Date:11/8/2009)...alth advocates committed to achieving meaningful h...7 "Tonight the U.S. Hou...oice of America,s families by passing the Affordab...t deliver, without delay, on the promise of meanin..., President and CEO of the National Alliance for H...
Breaking Medicine News(10 mins):Health News:College Invites Public to Explore Career Options in Health Care 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2
...e,s Closure to Have Disproportionate Impact On Lat...rved Groups, OAKLAND, Calif., Oct. 25 Sutter Hea...n Francisco will have a particularly,adverse impac...tee. CNA/NNOC presented the data at a San Francisc...
...new way to treat individuals with cancer that is b...nd kill cancer cells while leaving normal cells un...s. In a new study, David Kirn and colleagues at Je...er selecting a highly potent strain of poxvirus th...
...ADELPHIA A new Center for Excellence in Ethical, ...been established at the University of Pennsylvania...ols of Nursing and Arts and Sciences, the Wharton ...over $5 million over the next five years from the ...
...ue allows trapped air a way out, experts say , THU...o treat emphysema patients shows promise, research...uctive pulmonary disease (COPD), is a progressive,...s a minimally invasive, catheter-based bronchoscop...
...ER, Oct. 25 /PRNewswire-FirstCall/ - Biotech Holdi... it has signed an agreement, with,a private compan...ion of,its Sucanon Type II diabetes drug in four C...l population of approximately 33 million people, w...
...IL, Oct. 25 /PRNewswire-FirstCall/ - SXC Health So...that Mr. Gordon S. Glenn, Chairman and,Chief Execu...day, November,8, 2007 at 8:30 a.m. ET to discuss t...y. All interested parties can join the call by di...
Other Medicine News:Health News:CNA Presents New Data on Sutter's Medical Redlining 2Health News:CNA Presents New Data on Sutter's Medical Redlining 3Health News:Penn wins $5M to start center for ethical, legal and social implications research 2Health News:Penn wins $5M to start center for ethical, legal and social implications research 3Health News:SXC Health Solutions to Host Fiscal 2007 Third Quarter Financial Results Conference Call 2
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: